Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

EyePoint Pharmaceuticals Inc. buy Royal Bank of Canada

EyePoint Pharmaceuticals Inc.
Start price
€8.18
17.06.25 / 50%
Target price
€24.24
17.06.26
Performance (%)
37.50%
Price
€10.75
02.04.26
Summary
This prediction is currently active. With a performance of 37.50% the BUY prediction by Royal_Bank_of_Canada is a big success. This prediction currently runs until 17.06.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
EyePoint Pharmaceuticals Inc. 0.844% 0.844%
iShares Core DAX® 2.489% -5.941%
iShares Nasdaq 100 1.649% -2.462%
iShares Nikkei 225® 0.555% -7.597%
iShares S&P 500 1.347% -2.943%

Comments by Royal_Bank_of_Canada for this prediction

In the thread EyePoint Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 37.50%
Target price 24.237
Change
Ends at 17.06.26

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $28.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat

Royal Bank of Canada 
0
Report Share
17.06.25

Stopped prediction by Royal_Bank_of_Canada for EyePoint Pharmaceuticals Inc.

buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.59
06.11.25
€33.89
06.11.26
17.23%
02.04.26

Royal Bank of Canada 
06.11.25 50%